F · Healthcare

SCANDINAV.CHEMOTECH CL.B (8V6)

Biotechnology

SCANDINAV.CHEMOTECH CL.B (8V6) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 8V6

P/E ratio

25.00

SCANDINAV.CHEMOTECH CL.B (8V6) — FAQ

What is 8V6's P/E ratio?

The price-to-earnings (P/E) ratio for SCANDINAV.CHEMOTECH CL.B (8V6) is 25.00 (data as of 2026-05-23).

Does SCANDINAV.CHEMOTECH CL.B pay a dividend?

Dividend yield is not available in the current snapshot for SCANDINAV.CHEMOTECH CL.B (8V6). Check the MyAverix Finance app for the latest dividend data.

What sector is SCANDINAV.CHEMOTECH CL.B in?

SCANDINAV.CHEMOTECH CL.B (8V6) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 8V6 listed on?

8V6 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)